CD4 and AIDS: The seroprevalence of Toxocara infection in HIV/AIDS patients with CD4+ < 200 was 33.3% (4/12) and for the other groups were 50.0% (6/12) in 200 < CD4+ < 500, and 16.7% (2/12) in CD4+ > 500 (Table 2).